BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3780857)

  • 21. [The effect of paraoxon and sulfhydryl reagents on the binding of 3H-quinuclidinyl benzilate and 3H-methylscopolamine with synaptic membranes of rat cerebral cortex].
    Golovko AI; Sofronov GA; Kurganova TA; Kliuntina TV
    Biull Eksp Biol Med; 1994 Jul; 118(7):51-3. PubMed ID: 7919274
    [No Abstract]   [Full Text] [Related]  

  • 22. Kinetic studies of [3H]-N-methylscopolamine binding to muscarinic receptors in the rat central nervous system: evidence for the existence of three classes of binding sites.
    Waelbroeck M; Gillard M; Robberecht P; Christophe J
    Mol Pharmacol; 1986 Oct; 30(4):305-14. PubMed ID: 3762520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quaternary forms of classical muscarinic antagonists distinguish subpopulations of muscarinic receptors: correlation with gallamine-defined subpopulations.
    Ellis J; Lenox RH
    Biochem Biophys Res Commun; 1985 Feb; 126(3):1242-50. PubMed ID: 3977914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of the interactions of gallamine with muscarinic receptors from brain.
    Ellis J; Lenox RH
    Biochem Pharmacol; 1985 Jun; 34(12):2214-7. PubMed ID: 4004942
    [No Abstract]   [Full Text] [Related]  

  • 25. Agonist-induced muscarinic acetylcholine receptor down-regulation in intact rat brain cells.
    el-Fakahany EE; Lee JH
    Eur J Pharmacol; 1986 Dec; 132(1):21-30. PubMed ID: 3816962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscarinic acetylcholine receptor-mediated phosphoinositide turnover in cultured cerebellar granule cells: desensitization by receptor agonists.
    Xu J; Chuang DM
    J Pharmacol Exp Ther; 1987 Jul; 242(1):238-44. PubMed ID: 3039110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition of muscarinic cholinergic receptors in human SK-N-SH neuroblastoma cells by quaternary and tertiary ligands is dependent upon temperature, cell integrity, and the presence of agonists.
    Fisher SK
    Mol Pharmacol; 1988 Apr; 33(4):414-22. PubMed ID: 3357485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation between ligand trapping into intact cells and binding on muscarinic receptors.
    Gossuin A; Maloteaux JM; Trouet A; Laduron P
    Biochim Biophys Acta; 1984 May; 804(1):100-6. PubMed ID: 6722181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased binding of the muscarinic antagonist [3H]N-methylscopolamine in mouse brain following acute treatment with an organophosphate.
    Cioffi CL; el-Fakahany EE
    Eur J Pharmacol; 1986 Dec; 132(2-3):147-54. PubMed ID: 3816972
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
    Aronstam RS; Ryan US; Catravas JD
    Pharmacology; 1992; 44(6):324-33. PubMed ID: 1508962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-[3H]methylscopolamine labeling of non-M1, non-M2 muscarinic receptor binding sites in rat brain.
    Smith TD; Annis SJ; Ehlert FJ; Leslie FM
    J Pharmacol Exp Ther; 1991 Mar; 256(3):1173-81. PubMed ID: 2005579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini.
    Korc M; Ackerman MS; Roeske WR
    J Pharmacol Exp Ther; 1987 Jan; 240(1):118-22. PubMed ID: 2433426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Halothane effects on muscarinic acetylcholine receptor complexes in rat brain.
    Aronstam RS; Anthony BL; Dennison RL
    Biochem Pharmacol; 1986 Feb; 35(4):667-72. PubMed ID: 3947397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of cardiac muscarinic receptors recognized selectively by nonquaternary but not by quaternary ligands.
    Brown JH; Goldstein D
    J Pharmacol Exp Ther; 1986 Aug; 238(2):580-6. PubMed ID: 3016242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irreversible binding of acetylethylcholine mustard to cardiac cholinergic muscarinic receptors.
    Baker SP; Posner P
    Mol Pharmacol; 1986 Nov; 30(5):411-8. PubMed ID: 3773882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presynaptic muscarinic receptors on dopaminergic terminals in the nucleus accumbens.
    De Belleroche J; Kilpatrick IC; Birdsall NJ; Hulme EC
    Brain Res; 1982 Feb; 234(2):327-37. PubMed ID: 7059834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of muscarinic receptors in human submandibular salivary glands.
    Martos F; Bermudez R; Gomez A; Garcia A; Sanchez de la Cuesta F
    Eur J Pharmacol; 1985 Oct; 116(3):319-21. PubMed ID: 4076341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of ligand binding to receptors by competition kinetics. Application to muscarinic antagonists in rat brain cortex.
    Schreiber G; Henis YI; Sokolovsky M
    J Biol Chem; 1985 Jul; 260(15):8789-94. PubMed ID: 4019453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [3H]N-methylscopolamine dissociation from muscarine receptors affected by low concentrations of allosteric modulators.
    Christopoulos A; Mitchelson F
    Eur J Pharmacol; 1995 Aug; 290(3):259-62. PubMed ID: 7589221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of intact rat brain cells as a model to study regulation of muscarinic acetylcholine receptors.
    Lee JH; el-Fakahany EE
    Life Sci; 1985 Aug; 37(6):515-21. PubMed ID: 4021726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.